nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA2A—forebrain—attention deficit hyperactivity disorder	0.0255	0.0744	CbGeAlD
Enprofylline—ADORA1—forebrain—attention deficit hyperactivity disorder	0.022	0.0642	CbGeAlD
Enprofylline—ADORA2A—cardiovascular system—attention deficit hyperactivity disorder	0.0215	0.0629	CbGeAlD
Enprofylline—ADORA1—cardiovascular system—attention deficit hyperactivity disorder	0.0186	0.0543	CbGeAlD
Enprofylline—ADORA2B—nervous system—attention deficit hyperactivity disorder	0.0166	0.0485	CbGeAlD
Enprofylline—PDE4B—forebrain—attention deficit hyperactivity disorder	0.0163	0.0475	CbGeAlD
Enprofylline—ADORA2B—central nervous system—attention deficit hyperactivity disorder	0.016	0.0467	CbGeAlD
Enprofylline—ADORA2B—cerebellum—attention deficit hyperactivity disorder	0.0156	0.0457	CbGeAlD
Enprofylline—ADORA1—midbrain—attention deficit hyperactivity disorder	0.0145	0.0424	CbGeAlD
Enprofylline—PDE4A—cerebellum—attention deficit hyperactivity disorder	0.0139	0.0407	CbGeAlD
Enprofylline—ADORA2A—nervous system—attention deficit hyperactivity disorder	0.0138	0.0404	CbGeAlD
Enprofylline—ADORA2A—central nervous system—attention deficit hyperactivity disorder	0.0133	0.0389	CbGeAlD
Enprofylline—ADORA2A—cerebellum—attention deficit hyperactivity disorder	0.013	0.038	CbGeAlD
Enprofylline—ADORA2B—brain—attention deficit hyperactivity disorder	0.0127	0.0371	CbGeAlD
Enprofylline—ADORA1—nervous system—attention deficit hyperactivity disorder	0.0119	0.0349	CbGeAlD
Enprofylline—ADORA1—central nervous system—attention deficit hyperactivity disorder	0.0115	0.0336	CbGeAlD
Enprofylline—PDE4A—brain—attention deficit hyperactivity disorder	0.0113	0.0331	CbGeAlD
Enprofylline—ADORA1—cerebellum—attention deficit hyperactivity disorder	0.0112	0.0328	CbGeAlD
Enprofylline—PDE4B—midbrain—attention deficit hyperactivity disorder	0.0107	0.0314	CbGeAlD
Enprofylline—ADORA2A—brain—attention deficit hyperactivity disorder	0.0106	0.0309	CbGeAlD
Enprofylline—ADORA1—brain—attention deficit hyperactivity disorder	0.00912	0.0267	CbGeAlD
Enprofylline—PDE4B—nervous system—attention deficit hyperactivity disorder	0.00883	0.0258	CbGeAlD
Enprofylline—PDE4B—central nervous system—attention deficit hyperactivity disorder	0.0085	0.0248	CbGeAlD
Enprofylline—PDE4B—cerebellum—attention deficit hyperactivity disorder	0.00831	0.0243	CbGeAlD
Enprofylline—PDE4B—brain—attention deficit hyperactivity disorder	0.00675	0.0197	CbGeAlD
Enprofylline—ADORA1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00298	0.00453	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00294	0.00448	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00293	0.00445	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00291	0.00442	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0029	0.0044	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00286	0.00435	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00284	0.00431	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00281	0.00428	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00281	0.00427	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00279	0.00424	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00277	0.00421	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00276	0.0042	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00275	0.00419	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00274	0.00417	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00274	0.00417	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00274	0.00416	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00274	0.00416	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00273	0.00415	CbGpPWpGaD
Enprofylline—ADORA2B—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00273	0.00414	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00268	0.00407	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00265	0.00403	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00265	0.00403	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00263	0.004	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0026	0.00395	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0026	0.00395	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00258	0.00392	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00256	0.0039	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00255	0.00387	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00249	0.00378	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00241	0.00367	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00241	0.00367	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.0024	0.00365	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0024	0.00365	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00237	0.0036	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00237	0.0036	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00234	0.00356	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00233	0.00355	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00228	0.00347	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00224	0.00341	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00224	0.0034	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00224	0.0034	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00223	0.00339	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00218	0.00332	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00217	0.0033	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00216	0.00328	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00214	0.00325	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00212	0.00323	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00211	0.00321	CbGpPWpGaD
Enprofylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0021	0.00319	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0021	0.00319	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00315	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00315	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00207	0.00314	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00204	0.0031	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00203	0.00309	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00203	0.00309	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00203	0.00309	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00197	0.00299	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00195	0.00297	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00194	0.00295	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00192	0.00292	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00192	0.00292	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0019	0.00289	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0019	0.00288	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.00286	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00188	0.00286	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00186	0.00283	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00184	0.0028	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00184	0.00279	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00183	0.00278	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00183	0.00278	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00181	0.00275	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0018	0.00274	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0018	0.00274	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0018	0.00273	CbGpPWpGaD
Enprofylline—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00178	0.00271	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00178	0.00271	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00176	0.00268	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00174	0.00265	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00173	0.00263	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00171	0.00259	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00168	0.00256	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00166	0.00252	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00166	0.00252	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00157	0.00239	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00155	0.00236	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00155	0.00236	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00153	0.00233	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00153	0.00232	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0015	0.00228	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00147	0.00223	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00146	0.00223	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00143	0.00217	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00142	0.00216	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00141	0.00214	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00141	0.00214	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.00212	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00209	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00138	0.00209	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00137	0.00208	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00136	0.00207	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00136	0.00206	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00133	0.00203	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00132	0.002	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0013	0.00198	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00129	0.00197	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00128	0.00195	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00128	0.00194	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00126	0.00192	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00187	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00187	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.00186	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00122	0.00186	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00121	0.00184	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00118	0.0018	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00118	0.0018	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00179	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00118	0.00179	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00116	0.00177	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00115	0.00175	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00175	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00114	0.00174	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00114	0.00174	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00114	0.00173	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00112	0.0017	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00169	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00111	0.00168	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00111	0.00168	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0011	0.00168	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00109	0.00166	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00166	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00166	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00108	0.00164	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00108	0.00164	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00107	0.00163	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00107	0.00162	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00106	0.00161	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00105	0.00159	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00158	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00104	0.00158	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00104	0.00158	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00157	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00103	0.00156	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00103	0.00156	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00102	0.00155	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00155	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00102	0.00155	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00101	0.00153	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00153	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00101	0.00153	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00101	0.00153	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.001	0.00152	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.001	0.00152	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.001	0.00152	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000995	0.00151	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000989	0.0015	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000989	0.0015	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000977	0.00149	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000973	0.00148	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000961	0.00146	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000942	0.00143	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000938	0.00143	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000936	0.00142	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000931	0.00142	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000927	0.00141	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000926	0.00141	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000925	0.00141	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000915	0.00139	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000915	0.00139	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00091	0.00138	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000904	0.00137	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000898	0.00137	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00089	0.00135	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00089	0.00135	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000852	0.0013	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000842	0.00128	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000832	0.00126	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000827	0.00126	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000808	0.00123	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000804	0.00122	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000801	0.00122	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000788	0.0012	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000788	0.0012	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000778	0.00118	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000773	0.00118	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000773	0.00117	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000755	0.00115	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000751	0.00114	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000728	0.00111	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000727	0.00111	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000725	0.0011	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000715	0.00109	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000707	0.00108	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000706	0.00107	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000702	0.00107	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000702	0.00107	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000699	0.00106	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000676	0.00103	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00066	0.001	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000658	0.001	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000657	0.000999	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000655	0.000995	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000649	0.000987	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000644	0.000978	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000637	0.000969	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000636	0.000966	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000618	0.00094	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000614	0.000933	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000611	0.000929	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000597	0.000907	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000594	0.000904	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000592	0.0009	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00059	0.000897	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000584	0.000888	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000577	0.000877	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000575	0.000874	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000568	0.000863	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000557	0.000846	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00055	0.000836	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000547	0.000832	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000546	0.00083	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000541	0.000822	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00054	0.000822	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000538	0.000817	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000534	0.000812	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000507	0.000771	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000503	0.000765	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000497	0.000756	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000477	0.000726	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000461	0.000701	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000444	0.000675	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00043	0.000653	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000422	0.000642	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000417	0.000634	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000415	0.00063	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000389	0.000591	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000377	0.000572	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000353	0.000536	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000348	0.00053	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000272	0.000414	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00022	0.000334	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000199	0.000303	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000187	0.000284	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000185	0.000281	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000144	0.000219	CbGpPWpGaD
